Literature DB >> 16935573

Hereditary ataxia SCAN1 cells are defective for the repair of transcription-dependent topoisomerase I cleavage complexes.

Ze-Hong Miao1, Keli Agama, Olivier Sordet, Lawrence Povirk, Kurt W Kohn, Yves Pommier.   

Abstract

Hereditary spinocerebellar ataxia with axonal neuropathy (SCAN1) is caused by an inactivating mutation (H493R) in the enzyme tyrosyl-DNA phosphodiesterase (Tdp1), which removes blocked 3'-termini at DNA strand breaks. Using SCAN1 cells treated with the specific topoisomerase I (Top1) inhibitor camptothecin, we find enhanced levels of Top1 cleavage complexes (Top1cc) and defective reversal of Top1cc in SCAN1 Tdp1-deficient cells, indicating a direct involvement of Tdp1 in the repair of Top1cc. Because the defective removal of Top1cc and the hypersensitivity of SCAN1 cells to camptothecin are not affected by aphidicolin, we propose that Tdp1 is involved in the repair of Top1cc associated with transcription damage in SCAN1 cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16935573     DOI: 10.1016/j.dnarep.2006.07.004

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  56 in total

1.  Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs DNA damage induced by topoisomerases I and II and base alkylation in vertebrate cells.

Authors:  Junko Murai; Shar-yin N Huang; Benu Brata Das; Thomas S Dexheimer; Shunichi Takeda; Yves Pommier
Journal:  J Biol Chem       Date:  2012-02-27       Impact factor: 5.157

2.  Role of tyrosyl-DNA phosphodiesterase (TDP1) in mitochondria.

Authors:  Benu Brata Das; Thomas S Dexheimer; Kasthuraiah Maddali; Yves Pommier
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

3.  Synthesis and biological evaluation of the first dual tyrosyl-DNA phosphodiesterase I (Tdp1)-topoisomerase I (Top1) inhibitors.

Authors:  Trung Xuan Nguyen; Andrew Morrell; Martin Conda-Sheridan; Christophe Marchand; Keli Agama; Alun Bermingham; Alun Bermingam; Andrew G Stephen; Adel Chergui; Alena Naumova; Robert Fisher; Barry R O'Keefe; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2012-04-26       Impact factor: 7.446

4.  Identification of tyrosyl-DNA phosphodiesterase as a novel DNA damage repair enzyme in Arabidopsis.

Authors:  So-Young Lee; Hoyeun Kim; Hyun-Ju Hwang; Young-Min Jeong; Sang Hyeon Na; Je-Chang Woo; Sang-Gu Kim
Journal:  Plant Physiol       Date:  2010-09-27       Impact factor: 8.340

5.  In vitro complementation of Tdp1 deficiency indicates a stabilized enzyme-DNA adduct from tyrosyl but not glycolate lesions as a consequence of the SCAN1 mutation.

Authors:  Amy J Hawkins; Mark A Subler; Konstantin Akopiants; Jenny L Wiley; Shirley M Taylor; Ann C Rice; Jolene J Windle; Kristoffer Valerie; Lawrence F Povirk
Journal:  DNA Repair (Amst)       Date:  2009-02-10

Review 6.  Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2).

Authors:  Yves Pommier; Shar-yin N Huang; Rui Gao; Benu Brata Das; Junko Murai; Christophe Marchand
Journal:  DNA Repair (Amst)       Date:  2014-05-22

7.  WRN protects against topo I but not topo II inhibitors by preventing DNA break formation.

Authors:  Markus Christmann; Maja T Tomicic; Christopher Gestrich; Wynand P Roos; Vilhelm A Bohr; Bernd Kaina
Journal:  DNA Repair (Amst)       Date:  2008-10-15

Review 8.  DNA damage and repair: relevance to mechanisms of neurodegeneration.

Authors:  Lee J Martin
Journal:  J Neuropathol Exp Neurol       Date:  2008-05       Impact factor: 3.685

Review 9.  Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target?

Authors:  Haibo Wang; Prakash Dharmalingam; Velmarini Vasquez; Joy Mitra; Istvan Boldogh; K S Rao; Thomas A Kent; Sankar Mitra; Muralidhar L Hegde
Journal:  Mech Ageing Dev       Date:  2016-09-20       Impact factor: 5.432

Review 10.  DNA repair deficiency and neurological disease.

Authors:  Peter J McKinnon
Journal:  Nat Rev Neurosci       Date:  2009-01-15       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.